Juvenile Dermatomyositis Associated With Risk for Delayed Pubertal Development
Researchers studied growth and puberty in a multinational prospective cohort of children with juvenile dermatomyositis.
Pediatrics
Gene Polymorphisms in JIA-Associated Uveitis Not Linked to Idiopathic Pediatric Uveitis
Researchers addressed the genetic association between juvenile idiopathic arthritis-associated uveitis and idiopathic pediatric uveitis.
Abatacept Maintains Effective Diphtheria/Tetanus Vaccination Protection in Polyarticular-Course JIA
Researchers assessed protective antibody responses to diphtheria and tetanus vaccination in patients with polyarticular-course juvenile idiopathic arthritis.
Drug Reaction With Eosinophilia and Systemic Symptoms Linked to High Fatality Lung Disease in JIA
Drug reaction with eosinophilia and systemic symptoms (DReSS) with exposure to interleukin-1 or interleukin-6 inhibition may be linked to high fatality lung disease in systemic juvenile idiopathic arthritis.
Identification of a Protein Epitope Targeted by the Kawasaki Disease Antibody Response
A protein epitope targeted by the antibody response in children with Kawasaki disease has been identified.
Consensus Recommendations for the Diagnosis and Treatment of Secondary Osteoporosis in Children
The Osteogenesis Imperfecta and Childhood Osteoporosis Working Group of the Spanish Society of Pediatric Rheumatology developed guidelines for the prevention, diagnosis, and treatment of secondary childhood osteoporosis.
Live Attenuated Booster Vaccines Are Safe for Children With Rheumatic Disease on Immunosuppressive Therapy
Researchers collected retrospective data from patients with rheumatic diseases who received live attenuated booster doses of measles-mumps-rubella or measles-mumps-rubella varicella during treatment with immunosuppressive therapy.
Endothelial Biomarker Levels Elevated and Linked to Extramuscular Activity in Juvenile Dermatomyositis
Researchers analyzed endothelial biomarker levels in the peripheral blood of patients with juvenile dermatomyositis and their association with disease assessments.
Long-Term Registries of Biologic Therapies May Determine Risk for Rare Adverse Events in JIA
Investigators compared long-term safety with regard to rare adverse events between various biologics to treat juvenile idiopathic arthritis.
Knowledge, Attitude, and Current Practice of Primary Care Pediatricians Toward Immunization in Children With Rheumatic Diseases
Researchers aimed to describe the knowledge, attitude, and current practice of pediatricians toward immunizations in children with rheumatic diseases and identify barriers and facilitators that could promote uptake.
Next post in Pediatric Rheumatology
